Browse Category

Stock Market News 13 January 2026

SoFi stock rises as Trump’s 10% credit-card cap idea shakes lenders — what investors watch next

SoFi stock rises as Trump’s 10% credit-card cap idea shakes lenders — what investors watch next

SoFi shares rose 1.1% to $26.89 Tuesday afternoon, outperforming a 0.4% drop in the S&P 500 as investors assessed Trump’s proposed 10% cap on credit card interest rates. The policy push has rattled banks and payments firms, who warn it could restrict credit. Wall Street analysts see legal hurdles but say fintech lenders like SoFi could benefit if banks tighten lending. Focus turns to SoFi’s Jan. 30 earnings.
13 January 2026
ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow stock drops as Oppenheimer trims target — what to watch before earnings

ServiceNow shares fell 3.3% to $137.95 Tuesday after Oppenheimer cut its price target to $200, citing sector concerns ahead of earnings. Goldman Sachs began coverage with a Buy rating and $205 target, while Citi maintained its Buy and placed the stock on a 30-day catalyst watch. The iShares Expanded Tech-Software ETF dropped 2%. Investors remain cautious after ServiceNow’s $7.75 billion Armis acquisition.
Ofwat warns on South East Water outage as Severn Trent, United Utilities shares fall

Ofwat warns on South East Water outage as Severn Trent, United Utilities shares fall

Around 25,000 homes in Kent and Sussex lost water after a new supply failure at South East Water, prompting Ofwat to flag concern and launch a review. Shares in Severn Trent, United Utilities, and Pennon fell up to 2.6% as scrutiny intensified. South East Water is using tankers and bottled-water stations while restoring pressure, with full service expected by Wednesday. Some homes have faced four days without water.
13 January 2026
AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie shares fell 0.1% to $219.83 Tuesday after announcing a three-year U.S. pricing deal tied to tariff exemptions. The company also signed a $650 million licensing agreement with China’s RemeGen for rights to an experimental cancer drug and bought a manufacturing site in Arizona. Management is set to speak at the J.P. Morgan Healthcare Conference on Jan. 14.
Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam shares fell 0.1% to $370.39 Tuesday afternoon after the company projected 2026 net product revenue between $4.9 billion and $5.3 billion. Preliminary 2025 sales were disclosed at $2.987 billion. Analysts remained mostly positive but flagged possible weakness for Amvuttra next quarter. The update came as Alnylam outlined its new five-year strategy at the J.P. Morgan Healthcare Conference.
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals shares fell 10.6% after the FDA extended its review of partner Travere’s Filspari label expansion, resetting the decision deadline to April 13. Travere shares dropped 19%. The FDA classified the latest filing as a “major amendment” but did not request new safety or manufacturing data. The broader biotech sector was little changed.
Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola shares rose 0.5% to $70.83 Tuesday after the company set Feb. 10 for its Q4 and full-year earnings release and investor call. CEO-elect Henrique Braun and CFO John Murphy will speak at the CAGNY conference in Orlando on Feb. 17. Coke expects a $1 billion impairment charge in Q4 tied to its Africa bottling sale. PepsiCo shares gained 1.4% while the S&P 500 ETF slipped 0.4%.

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop